NEW YORK, June 20, 2014 /PRNewswire/ --
Today, Analysts Review released its analysts' notes regarding Apple Inc. (NASDAQ: AAPL), Whirlpool Corporation (NYSE: WHR), Harman International Industries, Inc. (NYSE: HAR), Sony Corporation (NYSE: SNE) and Royal Philips (NYSE: PHG). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/3928-100free.
Apple Inc. Analyst Notes
On June 2, 2014, Apple Inc. (Apple) announced the unveiling of iOS 8 with incredible new features for the users and tools for developers to create amazing new apps. According to the Company, iOS 8 offers a simpler, faster and more intuitive user experience that includes iCloud Photo Library, iCloud Drive, new Messages features, a new Health app, and predictive typing for Apple's QuickType keyboard. Apple informed that the iOS 8 will be available in fall 2014 as a free software update for iPhone 4s, iPhone 5, iPhone 5c, iPhone 5s, iPod touch 5th generation, iPad 2, iPad with Retina display, iPad Air, and iPad mini with retina display. The full analyst notes on Apple are available to download free of charge at:
Whirlpool Corporation Analyst Notes
On June 16, 2014, Whirlpool Corporation (Whirlpool) announced that it has received ENERGY STAR certification for clothes dryers. The Company informed that it has recently received certification from the US Environmental Protection Agency's (EPA) ENERGY STAR program on the Whirlpool brand Duet model WED87HED steam dryer. "Clothes dryers are the next frontier for significant residential energy efficiency gains, and we are proud to be the first manufacturer to offer Energy Star dryers," said Nick Gillespie, Senior Manager of Government Relations for Whirlpool. The full analyst notes on Whirlpool are available to download free of charge at:
Harman International Industries, Inc. Analyst Notes
On June 17, 2014, Harman International Industries, Inc. (Harman) announced that it has acquired sports headphones brand Yurbuds LLC (Yurbuds), making it a part of the Company's Lifestyle Division. "The talented - and athletic - management team at Yurbuds has helped drive the acceleration of the fast-growing niche of sports headphones and wearables, with best in class design and a rich pipeline of future innovations to enhance the athlete experience," said Dinesh C. Paliwal, Chairman, President and CEO of Harman. "We see exciting opportunities to leverage the technologies, brands and distribution systems from our organizations to develop the next generation of headphones designed specifically for athletes." The full analyst notes on Harman are available to download free of charge at:
Sony Corporation Analyst Notes
On June 3, 2014, Sony Corporation (Sony) announced that it has established Esstalion Technologies, Inc. with Hydro-Quebec as a business venture to research and develop large-scale energy storage systems for power grids. "By combining Hydro-Québec's know-how in the operation and control of electric power systems as well as our lithium-ion battery material technology, together with Sony's expertise and leadership in rechargeable batteries and highly scalable module systems, we think we will succeed in developing a high-performance energy storage system for large-scale applications, as well as battery material technology suitable for use in power grids," said Thierry Vandal, President and CEO of Hydro-Quebec. The full analyst notes on Sony are available to download free of charge at:
Royal Philips Analyst Notes
On June 5, 2014, Royal Philips and Elekta jointly announced that The Institute of Cancer Research (ICR), London, will join the Elekta MR Linac Research Consortium to develop magnetic resonance imaging (MRI) guided therapy system for cancer treatment. "The addition of The Institute of Cancer Research (ICR) to the consortium further strengthens this growing partnership of clinical centers," said Niklas Savander, Elekta's President and CEO. "The ICR is a prominent cancer research institute and has contributed significantly in this arena for over a century. Its unique partnership with The Royal Marsden and 'bench-to-bedside' approach allows the ICR to deliver exceptional results. All of these factors make the ICR and The Royal Marsden a perfect fit as we advance MRI-guided radiotherapy." The full analyst notes on Philips are available to download free of charge at:
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Analysts Review